🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/07/2015 29,30 29,95 28,85 29,36 +3,78% 3,75% 850.400
08/07/2015 29,07 29,35 28,19 28,29 -4,07% 3,99% 723.900
07/07/2015 30,01 30,20 28,56 29,49 -1,40% 5,46% 763.700
06/07/2015 29,40 30,58 29,17 29,91 -0,76% 4,80% 615.200
02/07/2015 29,69 30,43 29,38 30,14 +1,31% 3,54% 663.600
01/07/2015 31,13 31,24 29,17 29,75 -2,23% 6,65% 1.343.000
30/06/2015 28,80 30,93 28,53 30,43 +7,98% 8,33% 2.359.600
29/06/2015 31,78 31,83 28,03 28,18 -9,85% 11,96% 3.439.400
26/06/2015 32,65 32,80 30,17 31,26 -4,29% 8,06% 1.600.900
25/06/2015 32,45 32,75 31,80 32,66 +1,90% 2,93% 897.300
24/06/2015 32,57 33,16 31,73 32,05 -1,93% 4,39% 1.931.600
23/06/2015 31,68 32,94 31,13 32,68 +6,24% 5,71% 1.938.400
22/06/2015 30,57 31,34 30,01 30,76 +1,35% 4,35% 1.371.300
19/06/2015 29,76 30,43 29,22 30,35 +2,05% 4,07% 2.207.500
18/06/2015 29,19 29,99 29,11 29,74 +2,20% 3,01% 1.233.600
17/06/2015 28,32 30,30 28,32 29,10 +2,83% 6,99% 1.394.500
16/06/2015 28,60 29,10 28,27 28,30 -0,84% 2,90% 776.600
15/06/2015 27,78 29,28 27,39 28,54 +3,07% 6,80% 1.161.300
12/06/2015 28,11 28,19 27,15 27,69 -2,16% 3,70% 732.600
11/06/2015 28,13 28,51 27,76 28,30 +0,64% 2,67% 780.500
10/06/2015 27,08 28,76 26,64 28,12 +4,11% 7,83% 1.854.600
09/06/2015 26,34 27,09 26,02 27,01 +3,09% 4,06% 1.149.500
08/06/2015 26,51 27,16 25,85 26,20 -1,91% 4,94% 866.200
05/06/2015 25,38 26,89 25,15 26,71 +5,07% 6,86% 1.007.000
04/06/2015 25,30 25,86 25,03 25,42 -0,27% 3,28% 623.100
03/06/2015 25,21 25,55 24,86 25,49 +1,23% 2,74% 657.300
02/06/2015 24,73 25,53 24,56 25,18 +0,92% 3,92% 607.700
01/06/2015 25,87 25,99 24,61 24,95 -2,62% 5,33% 1.010.500
29/05/2015 25,38 26,11 24,92 25,62 +0,43% 4,69% 1.044.100
28/05/2015 25,89 26,14 25,07 25,51 -2,41% 4,13% 1.047.500